SHL Telemedicine Ltd (SHLT): Growth-Adjusted Market Cap to Net Income

Brandmark of shl-telemedicine.com (SHLT)

Risks for SHL Telemedicine Ltd. (SHLT) are tied to regulatory barriers and shifts in government subsidies, as reflected by the PEG ratio trend, where the current metric stands at 0.00. Service pricing is capped by official insurance tariffs, although demand in the US and Germany remains stable. Management is focusing on expanding its US market presence and implementing wearable ECG systems to reduce hospitalization costs.

SHLT: SHL Telemedicine Price/Earnings to Growth Ratio 02/21/2024 - 04/13/2025

SHL Telemedicine Ltd. (SHLT) - metric breakdowns and financial figures

- stock price and consensus target price:
General company analysis:SHLT - SHL Telemedicine Ltd.
Finished products of SHL Telemedicine, Ltd.

The specifics of proprietary ECG software and stringent FDA oversight drive the profit dynamics reflected in the average PEG ratio for SHL Telemedicine Ltd. (SHLT). This indicator benchmarks the P/E multiple against revenue growth rates, enabling the identification of undervalued assets at values below one and assessing business efficiency relative to its expansion within the telemedicine sector.